GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Revenue

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Revenue : HK$44.79 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Revenue?

Cryofocus Medtech (Shanghai) Co's revenue for the six months ended in Jun. 2023 was HK$20.69 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$44.79 Mil. Cryofocus Medtech (Shanghai) Co's Revenue per Share for the six months ended in Jun. 2023 was HK$0.09. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.19.

During the past 12 months, the average Revenue per Share Growth Rate of Cryofocus Medtech (Shanghai) Co was 225.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Cryofocus Medtech (Shanghai) Co Revenue Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Revenue Chart

Cryofocus Medtech (Shanghai) Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Revenue
10.73 27.46 30.32 44.79

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue Get a 7-Day Free Trial - 12.08 18.81 20.69 24.10

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Revenue

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryofocus Medtech (Shanghai) Co's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Revenue distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Revenue falls into.



Cryofocus Medtech (Shanghai) Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$44.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cryofocus Medtech (Shanghai) Co  (HKSE:06922) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Cryofocus Medtech (Shanghai) Co Revenue Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Traded in Other Exchanges
N/A
Address
Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines